US regulator orders makers of weight-loss drugs to carry blindness risk warning

翻译尚未完成，当前显示原文。

Food and Drug Administration cites increased risk of rare eye condition that can cause permanent vision loss in users of GLP-1s

阅读完整 Veytics 简报

我们公开展示核心要点。创建免费账户后可继续阅读全文、保存、讨论，并结合市场和 OSINT 背景分析。